Knockdown of GSDMD has been demonstrated to suppress tumor progression by promoting the mitochondrial apoptotic pathway and inhibiting the epidermal growth factor receptor (EGFR)/Akt pathway [104]. This evidence concerns the gene EGFR and neoplasm.